Stock-Based Compensation for Amgen (AMGN)
Stock-Based Compensation for Amgen (AMGN): headline value $369.00M · YoY -100.0%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
AMGN
Currently viewingStock-Based CompensationSwitch metric
Latest period
$369.00M
YoY change
-100.0%
5Y CAGR
-100.0%
Peak year (2024)
$530.00M
Latest annual
$0
Stock-Based Compensation history chart for Amgen (AMGN) from 1988 to 2025
Stock-Based Compensation history table for Amgen (AMGN) from 1988 to 2025
| Fiscal year | Period ended | Reported | Stock-Based Compensation | YoY |
|---|---|---|---|---|
| 2025 | $0 | -100.0% | ||
| 2024 | $530.00M | +23.0% | ||
| 2023 | $431.00M | +7.5% | ||
| 2022 | $401.00M | +17.6% | ||
| 2021 | $341.00M | +3.3% | ||
| 2020 | $330.00M | +7.1% | ||
| 2019 | $308.00M | -1.0% | ||
| 2018 | $311.00M | -5.5% | ||
| 2017 | $329.00M | +5.8% | ||
| 2016 | $311.00M | -3.4% | ||
| 2015 | $322.00M | -21.1% | ||
| 2014 | $408.00M | +1.2% | ||
| 2013 | $403.00M | +11.3% | ||
| 2012 | $362.00M | +6.2% | ||
| 2011 | $341.00M | -3.4% | ||
| 2010 | $353.00M | +24.3% | ||
| 2009 | $284.00M | — | ||
| 2008 | $0 | — | ||
| 2007 | $0 | — | ||
| 2006 | $0 | — | ||
| 2005 | $0 | — | ||
| 2004 | $0 | — | ||
| 2003 | $0 | — | ||
| 2002 | $0 | — | ||
| 2001 | $0 | — | ||
| 2000 | $0 | — | ||
| 1999 | $0 | — | ||
| 1998 | $0 | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | — | ||
| 1992 | $0 | — | ||
| 1991 | $0 | — | ||
| 1990 | $0 | — | ||
| 1989 | $0 | — | ||
| 1988 | $0 | — |
Stock-Based Compensation values are taken from Amgen's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Amgen (AMGN) stock-based compensation is $0 – plunged 100.0% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Amgen stock-based compensation compounded at -100.0% per year, with a net decline across the window.
The highest annual stock-based compensation of $530.00M was reported in 2024. The lowest in the available history was $0 in 1988.
Among 8 Healthcare peers, Amgen (AMGN) ranks 5th; the peer median for stock-based compensation is $313.00M.
Amgen Stock-Based Compensation by Year
Amgen Stock-Based Compensation 2025: $0
Amgen stock-based compensation in 2025 was $0, plunged 100.0% below 2024.
Amgen Stock-Based Compensation 2024: $530.00M
Amgen stock-based compensation in 2024 was $530.00M, grew 23.0% from 2023. This figure represents the highest annual value in the available history.
Amgen Stock-Based Compensation 2023: $431.00M
Amgen stock-based compensation in 2023 was $431.00M, grew 7.5% from 2022.
Amgen Stock-Based Compensation 2022: $401.00M
Amgen stock-based compensation in 2022 was $401.00M, grew 17.6% from 2021.
Amgen Stock-Based Compensation 2021: $341.00M
Amgen stock-based compensation in 2021 was $341.00M.
See more financial history for Amgen (AMGN).
Sector peers — Stock-Based Compensation
Companies in the same sector as Amgen, ranked by their latest stock-based compensation.
| Company | Stock-Based Compensation | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $1.35B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $971.00M | Healthcare |
| AbbVie Inc. (ABBV) | $955.00M | Healthcare |
| Eli Lilly and Company (LLY) | $626.00M | Healthcare |
| AstraZeneca PLC (AZN) | $0 | Healthcare |
| Merck & Co., Inc. (MRK) | $0 | Healthcare |
| Novo Nordisk A/S (NVO) | $0 | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $0 | Healthcare |
Frequently asked questions
What is Amgen's stock-based compensation?
Latest reported stock-based compensation for Amgen (AMGN) is $369.00M (period ending December 31, 2025).
How has Amgen stock-based compensation changed year-over-year?
Amgen (AMGN) stock-based compensation changed -100.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Amgen stock-based compensation?
Amgen (AMGN) stock-based compensation compound annual growth rate is -100.0% over the most recent 5 years available.
When did Amgen stock-based compensation hit its highest annual value?
Amgen stock-based compensation reached its highest annual value of $530.00M in 2024.
What was Amgen stock-based compensation in 2024?
Amgen (AMGN) stock-based compensation in 2024 was $530.00M.
What was Amgen stock-based compensation in 2025?
Amgen (AMGN) stock-based compensation in 2025 was $0.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
AMGN Overview
Company profile, financial tools, and key metrics
AMGN Revenue Counter
Earns $1,166 every second. See per minute, hour, and day.
AMGN Earnings Counter
Earns $244.51 per second net profit. See per minute, hour, and day.
AMGN Economic Scale
Exceeds El Salvador's GDP. Compare with world economies.
AMGN What If Invested
What if you had invested $1,000? See historical returns from any date.
AMGN How It Makes Money
Discover visual breakdown of $36.77B in revenue — where it comes from and where it goes.
AMGN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AMGN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AMGN Daily Price Character
Balanced · 48.1% historical win rate (green days). Streaks & record days.
AMGN Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
AMGN Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
AMGN Dividend Profile
Yield: 2.86%. Safety: 8/8. See full history.
AMGN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AMGN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.